CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Net revenue	$ 46,006	$ 35,851	$ 129,875	$ 104,689
Cost of goods sold	8,491	7,096	22,920	20,209
Gross profit	37,515	28,755	106,955	84,480
Operating expenses
Research and development costs	6,337	4,118	18,100	11,254
Selling, general, and administrative	39,667	28,968	114,857	79,009
Total operating expenses	46,004	33,086	132,957	90,263
Operating loss	(8,489)	(4,331)	(26,002)	(5,783)
Other income (expense)
Other income (expense)	59	(98)	610	(124)
Interest expense, net	(1,093)	(573)	(2,865)	(1,174)
Total other expense	(1,034)	(671)	(2,255)	(1,298)
Loss before income taxes	(9,523)	(5,002)	(28,257)	(7,081)
Income tax expense	201	105	306	437
Net loss	(9,724)	(5,107)	(28,563)	(7,518)
Less: cumulative dividends on Series B convertible preferred stock	0	(574)	0	(1,516)
Net loss attributable to common stockholders	(9,724)	(5,681)	(28,563)	(9,034)
Foreign currency translation adjustment	(588)	(121)	(1,505)	(575)
Comprehensive loss	$ (10,312)	$ (5,802)	$ (30,068)	$ (9,609)
Weighted-average number of common stocks outstanding:
Basic	76,850,949	47,005,334	76,595,118	46,926,344
Diluted	76,850,949	47,005,334	76,595,118	46,926,344
Net loss per share attributable to common stockholders:
Basic	$ (0.13)	$ (0.12)	$ (0.37)	$ (0.19)
Diluted	$ (0.13)	$ (0.12)	$ (0.37)	$ (0.19)